Key facts
- ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for Voyager Therapeutics, Inc. Common Stock, $0.001 par value (SCLX).
- Disclosed ownership: 8.6%.
- Date of event: 30 Jun 2025.
ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Voyager Therapeutics, Inc. Common Stock, $0.001 par value (SCLX)
- Filing Manager
- ARMISTICE CAPITAL, LLC
- Reporting Manager
- Armistice Capital, LLC
- Symbol
- SCLX
- Shares outstanding
- 55,491,329 shares
- Disclosed Ownership
- 4,800,000 shares
- Ownership
- 8.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 21:40:36 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Key filing fact
ARMISTICE CAPITAL, LLC disclosed 8.6% ownership in Voyager Therapeutics, Inc. Common Stock, $0.001 par value (SCLX) on 30 Jun 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 21:40.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 8.6% | 4,800,000 | 0 | 4,800,000 | /s/ Steven Boyd | Steven Boyd - Managing Member | |
| Steven Boyd | 8.6% | 4,800,000 | 0 | 4,800,000 | /s/ Steven Boyd | Steven Boyd |
CIK / CUSIP context first